Literature DB >> 14976609

Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease.

Susana A Laucella1, Miriam Postan, Diana Martin, Bolyn Hubby Fralish, Maria C Albareda, Maria G Alvarez, Bruno Lococo, Gustavo Barbieri, Rodolfo J Viotti, Rick L Tarleton.   

Abstract

This study sought to quantify CD8(+) T cell responses to Trypanosoma cruzi and to identify potential links between these responses and the severity of disease in humans. In the majority of patients with Chagas disease, staining with class I major histocompatibility complex tetramers and analysis of interferon (IFN)- gamma ELISPOT responses to a panel of known cytotoxic T lymphocyte target epitopes from T. cruzi failed to identify parasite-specific CD8(+) T cells. However, the frequency of individuals with positive ELISPOT responses was higher in areas of active transmission. Analysis of IFN- gamma ELISPOT responses to a parasite lysate revealed a very high frequency of responders among patients with mild clinical disease and a very low frequency of responders among those with the most severe form of the disease. These data suggest that the frequency of IFN- gamma -producing T cells in patients with chronic Chagas disease is associated with the history of recent exposure and with the clinical status of the patient.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14976609     DOI: 10.1086/381682

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  86 in total

1.  Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease.

Authors:  Kathryn Jones; Leroy Versteeg; Ashish Damania; Brian Keegan; April Kendricks; Jeroen Pollet; Julio Vladimir Cruz-Chan; Fabian Gusovsky; Peter J Hotez; Maria Elena Bottazzi
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

2.  Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi.

Authors:  Silvia I Cazorla; Pablo D Becker; Fernanda M Frank; Thomas Ebensen; María J Sartori; Ricardo S Corral; Emilio L Malchiodi; Carlos A Guzmán
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

Review 3.  Current concepts in immunoregulation and pathology of human Chagas disease.

Authors:  Walderez O Dutra; Kenneth J Gollob
Journal:  Curr Opin Infect Dis       Date:  2008-06       Impact factor: 4.915

4.  Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease.

Authors:  Walderez Ornelas Dutra; Cristiane Alves Silva Menezes; Fernanda Nobre Amaral Villani; Germano Carneiro da Costa; Alexandre Barcelos Morais da Silveira; Débora d'Avila Reis; Kenneth J Gollob
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

5.  Changes in Trypanosoma cruzi-specific immune responses after treatment: surrogate markers of treatment efficacy.

Authors:  Susana A Laucella; Damián Pérez Mazliah; Graciela Bertocchi; María G Alvarez; Gretchen Cooley; Rodolfo Viotti; María C Albareda; Bruno Lococo; Miriam Postan; Alejandro Armenti; Rick L Tarleton
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

6.  Methodological advances in drug discovery for Chagas disease.

Authors:  Juan M Bustamante; Rick L Tarleton
Journal:  Expert Opin Drug Discov       Date:  2011-06       Impact factor: 6.098

7.  Assessment of CD8(+) T cell differentiation in Trypanosoma cruzi-infected children.

Authors:  María Cecilia Albareda; Gabriela Carina Olivera; Ana María De Rissio; Miriam Postan
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

8.  Perturbed T cell IL-7 receptor signaling in chronic Chagas disease.

Authors:  M Cecilia Albareda; Damián Perez-Mazliah; M Ailén Natale; Melisa Castro-Eiro; María G Alvarez; Rodolfo Viotti; Graciela Bertocchi; Bruno Lococo; Rick L Tarleton; Susana A Laucella
Journal:  J Immunol       Date:  2015-03-13       Impact factor: 5.422

9.  Cellular immune response from Chagasic patients to CRA or FRA recombinant antigens of Trypanosoma cruzi.

Authors:  Virginia M B Lorena; Alinne F A Verçosa; Raquel C A Machado; Lucas Moitinho-Silva; Maria G A Cavalcanti; Edimilson D Silva; Antonio G P Ferreira; Rodrigo Correa-Oliveira; Valéria R A Pereira; Yara M Gomes
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

10.  The liver plays a major role in clearance and destruction of blood trypomastigotes in Trypanosoma cruzi chronically infected mice.

Authors:  Luiz Roberto Sardinha; Tainá Mosca; Rosa Maria Elias; Rogério Silva do Nascimento; Lígia A Gonçalves; Daniella Zanetti Bucci; Cláudio Romero Farias Marinho; Carlos Penha-Gonçalves; Maria Regina D'Império Lima; José Maria Alvarez
Journal:  PLoS Negl Trop Dis       Date:  2010-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.